Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Bristol Myers Squibb (BMY)

Bristol-Myers Squibb posts J.P. Morgan conference investor presentation dated January 12, 2026

Neutral Impact 2 of 5 other Written later

Bristol-Myers Squibb furnished an investor presentation from its 44th Annual J.P. Morgan Healthcare Conference, posted to its website on January 12, 2026. The deck covers Growth Portfolio sales, pipeline timelines, and capital returns, but it reports no new quarterly results or guidance changes.

Key points

  • Growth Portfolio sales rose 17% for the nine months ended 9/30/25 versus the same period in 2024
  • About $14.5 billion in dividends and about $8 billion in share repurchases over the past three years, per the presentation
  • Company cites 94 consecutive years of dividend payments; latest dividend declared 12/10/2025 and payable 2/2/2026

The filing

CompanyBristol Myers Squibb (BMY)
Form8-K, current report
Filed with the SECJan 12, 2026, 10:20 AM ET
Accession number0001140361-26-000929

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 2:16 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 12, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.